Loading…

Verge Medical acquired the RoVo System and its patented Temporary Occlusion Embolectomy (TOE) technology from 2MG Medical to enhance its peripheral embolic protection portfolio.
“The acquisition enhances Verge's expanding portfolio of targeted, setting-specific solutions for coronary and peripheral vascular interventions.”prnewswire.com
Summarized from public sources; check the original articles before acting on it.